NVO: Novo Nordisk – ADR Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) n/a
Enterprise Value ($M) n/a
Book Value ($M) 79,874.00
Book Value / Share 35.60
Price / Book n/a
NCAV ($M) -56,208.00
NCAV / Share -25.05
Price / NCAV n/a

Profitability (mra)
Return on Invested Capital (ROIC) 0.56
Return on Assets (ROA) 0.31
Return on Equity (ROE) 0.92

Liquidity (mrq)
Quick Ratio 0.67
Current Ratio 0.86

Balance Sheet (mrq) ($M)
Current Assets 113,943.00
Assets 250,025.00
Liabilities 170,151.00
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 176,954.00
Operating Income 75,620.00
Net Income 55,525.00

Cash Flow Statement (mra) ($M)
Cash From Operations 78,887.00
Cash from Investing -24,918.00
Cash from Financing -51,797.00

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)
Change
(%)
02-23 13G/A BlackRock Inc. 6.50 -8.05

Top 13F Investors Shares
(1000)
Change
(%)
Value
($1000)
Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2023-05-31 148,909 841,917 17.69
2023-05-30 190,858 1,257,243 15.18
2023-05-26 158,843 963,081 16.49

(click for more detail)

Similar Companies
ABBV – Abbvie Inc ABT – Abbott Laboratories
ADCT – Adc Therapeutics SA AMRX – Amneal Pharmaceuticals Inc – Class A
APN – Apeiron Capital Investment Corp – Class A


Financial data and stock pages provided by
Fintel.io